These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 59463)

  • 1. Nonsurgical treatment of human benign prostatic hyperplasia.
    Scott WW; Coffey DS
    Vitam Horm; 1975; 33():439-65. PubMed ID: 59463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormonal treatment benign prostatic hyperplasia. A review].
    Schoonees R; de Klerk JN
    S Afr Med J; 1972 Sep; 46(37):1337-9. PubMed ID: 4118059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative treatment of benign prostatic hyperplasia (author's transl)].
    Schoenenberger A; Hauri D
    Ther Umsch; 1982 Apr; 39(4):260-7. PubMed ID: 6179177
    [No Abstract]   [Full Text] [Related]  

  • 4. [The endocrine profile in prostatic cancer: therapeutic implications].
    Calvo Mateo MA; Castellanos Llorens JM; Galán Ortega A
    Actas Urol Esp; 1981; 5(1):3-12. PubMed ID: 7015803
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical management of prostatic hyperplasia.
    Caine M
    Compr Ther; 1986 Dec; 12(12):21-5. PubMed ID: 2431827
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen metabolism in patients with benign prostatic hypertrophy.
    Voigt KD; Horst HJ; Krieg M
    Vitam Horm; 1975; 33():417-38. PubMed ID: 59462
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects and metabolism of hormones in normal and neoplastic prostate tissue.
    Ofner P
    Vitam Horm; 1968; 26():237-91. PubMed ID: 4181431
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of an anti-androgen, SH 714 (6-chlor-delta-6-1, 2-alpha-methylen-17-alpha-hydroxyprogesterone acetate, cyproterone acetate) on canine prostatic hyperplasia.
    Neri RO; Casmer C; Zeman WV; Fielder F; Tabachnick II
    Endocrinology; 1968 Feb; 82(2):311-7. PubMed ID: 4170420
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of antiandrogens.
    Namer M
    J Steroid Biochem; 1988 Oct; 31(4B):719-29. PubMed ID: 2462132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic basis for hormonal theapy in carcinoma of the prostate.
    Walsh PC
    Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and conservative treatment of the prostatic adenoma].
    Brosig W
    Langenbecks Arch Chir; 1972; 332():441-4. PubMed ID: 4119013
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal treatment of advanced cancer of the prostate].
    de Leval J
    Rev Med Liege; 1991 Nov; 46(11):577-82. PubMed ID: 1754776
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormone therapy of prostatic hypertrophy--present status and the future].
    Komase M
    Horumon To Rinsho; 1970 Jul; 18(7):530-6. PubMed ID: 4194903
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormone therapy of prostatic carcinoma].
    Rothauge CF; Breitwieser P; Wildberger JE
    Z Allgemeinmed; 1971 Mar; 47(7):337-44. PubMed ID: 5558581
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of testosterone metabolism in the human prostate.
    Tan SY; Antonipillai I; Murphy BE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):936-41. PubMed ID: 4138158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is the role of hormonal treatments in acne?].
    Drapier-Faure E; Faure M
    Ann Dermatol Venereol; 2001 Apr; 128 Supp 1():S19-24; discussion S33. PubMed ID: 11450396
    [No Abstract]   [Full Text] [Related]  

  • 17. 4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate.
    Bartsch G; Daxenbichler G; Rohr HP
    J Steroid Biochem; 1983 Jul; 19(1A):147-54. PubMed ID: 6193337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
    Bartsch G; Oberholzer M; Rohr HP
    Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles of endocrine manipulation in the treatment of prostatic cancer.
    Neumann F
    Prog Clin Biol Res; 1985; 185A():73-98. PubMed ID: 3898136
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal management of the benign obstructing prostate: use of combined androgen-estrogen therapy.
    KAUFMAN JJ; GOODWIN WE
    J Urol; 1959 Jan; 81(1):165-71. PubMed ID: 13631794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.